Introduction to PROTACs

In an upcoming free webinar, attendees will delve into the world of proteolysis targeting chimeras (PROTACs)—a groundbreaking innovation poised to revolutionize drug discovery by enabling the selective degradation of specific proteins. This state-of-the-art technique promises enhanced precision in targeted therapies, significantly minimizing unwanted side effects associated with conventional treatments.

Webinar Details

Scheduled for Wednesday, October 9, 2024, at 11 AM EDT (4 PM BST), the session will feature insight from leading experts in the field. Among them are Dr. Shanavas Alikunju, Senior Vice President & Head of Discovery Biology Solutions at Aragen Life Sciences, and Indrani Sarkar, Associate Vice President of Assay Development and Screening.

Key Discussions

Key discussions will revolve around the revolutionary mechanism that sets PROTACs apart as targeted protein degraders, enabling the targeting of "undruggable" proteins—those that have eluded successful therapeutic intervention until now. Participants will discover how this technology heralds a new era in personalized medicine, particularly in effectively addressing complex diseases such as cancer and neurodegenerative disorders.

Innovative Applications in Agriculture

Moreover, attendees will learn about innovative applications of PROTACs in agriculture, highlighting their potential to enhance crop protection strategies and contribute to sustainable agricultural practices. This could lead to more resilient crops and a reduced environmental impact of farming.

Conclusion and Registration

This webinar is an opportunity to gain a deeper understanding of the transformative capabilities of PROTACs. To reserve your spot and unlock the potential of this next-generation technology, be sure to register today!

More Information

For more details on the event or to sign up for the webinar, visit the dedicated website for PROTACs: Breaking Boundaries in Drug Discovery. Stay ahead in the rapidly evolving life sciences arena—don’t miss this chance to be part of a pivotal discussion that could redefine both the drug discovery landscape and agricultural innovation!